MAIN

Session 8: Immunotherapies alone or in combination with other therapies (Part I)

BREAK

Session 7: New topics in cancer immunology and immunotherapy

Educational Lecture

Keynote Lecture

BREAK

Session 6: Tumor Biomarkers (II)

BREAK

Educational Lecture (AstraZeneca)

Session 5: Novel anticancer therapies (part II)